How Is Cancer Diagnosed?

 

If your doctor suspects that you have cancer based on your symptoms or the results of a screening test or clinical examination, he or she will order certain diagnostic tests to find out whether you have abnormal cells and, if so, whether they are malignant (cancerous) or non-malignant (non-cancerous). If the tests show that the cells are malignant, you may need more tests to find out more about the cancer cells.

Many types of tests are used to diagnose cancer:

Biopsies -- A biopsy is usually the only way to tell for sure whether you have cancer or not. The doctor cuts out a small piece of tissue (a groupf of similar cells) and sends it to a laboratory to be studied. A pathologist (a doctor who specializes in diagnosing diseases) looks at the tissue under a microscope to see whether it has cancerous cells.

Imaging tests -- These tests or evaluation procedures produce pictures of areas inside the body. They include x-rays, like mammograms, computed tomography (CT or CAT) scans, and magnetic resonance imaging (MRI) scans. Other common imaging tests include ultrasound and positron emission tomography (PET) scans.

Laboratory tests -- A laboratory technician measures substances in the blood or urine that can indicate how advanced the cancer is or other features of your cancer.

Genomics tests -- Polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), and other genomics tests (tests of genes and their functions) can find mutations (unusual changes) in certain genes that are known to cause cancer.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health